首页> 外国专利> ISOLATED POLYPEPTIDE AND PHARMACEUTICAL COMPOSITION COMPRISING IT FOR THE DIAGNOSIS OF RETINAL DYSTROPHY AND USE THEREOF IN THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF RETINAL DYSTROPHY

ISOLATED POLYPEPTIDE AND PHARMACEUTICAL COMPOSITION COMPRISING IT FOR THE DIAGNOSIS OF RETINAL DYSTROPHY AND USE THEREOF IN THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF RETINAL DYSTROPHY

机译:包含其的分离的多肽和药物组合物,用于诊断视网膜营养不良,并将其用于制备治疗视网膜营养不良的药物

摘要

Disclosed are methods and compositions for early diagnosis, monitoring and treatment of retinal dystrophy, age-related macular degeneration, Bardet-Biedel syndrome, Bassen-kornzweig syndrome, best disease, chroidema, gyrate atrophy, congenital amourosis, refsun syndrome, stargardt disease and Usher syndrome. In particular, the invention relates to a protein, termed 2Rdcvf1,” that is differentially transcribed and expressed in subjects suffering from retinal dystrophies and the like, such as retinal dystrophy and age-related macular degeneration compared with non-sufferers, antibodies which recongnize this protein, and methods for diagnosing such conditions.
机译:公开了用于早期诊断,监测和治疗视网膜营养不良,年龄相关性黄斑变性,Bardet-Biedel综合征,Bassen-kornzweig综合征,最佳疾病,脉络膜炎,旋回萎缩,先天性阿米色病,refsun综合征,stargardt病和Usherer的方法和组合物综合症。特别地,本发明涉及一种称为2Rdcvf1的蛋白质。与患有非营养性疾病的人相比,在患有视网膜营养不良等的受试者(例如视网膜营养不良和与年龄相关的黄斑变性)中差异表达和表达“非营养性”,识别该蛋白的抗体以及诊断此类疾病的方法。

著录项

  • 公开/公告号IL158013B

    专利类型

  • 公开/公告日2010-12-30

    原文格式PDF

  • 申请/专利权人 NOVARTIS AG;UNIVERSITE DE STRASBOURG;

    申请/专利号IL158013

  • 发明设计人

    申请日2003-09-18

  • 分类号G01N33/53;A61K38/00;A61K48/00;A61P27/02;C07K14/47;C07K16/18;C12N5/10;C12N15/09;C12N15/12;C12P21/02;C12P21/08;C12Q1/68;C12R1/91;G01N33/566;G01N33/577;

  • 国家 IL

  • 入库时间 2022-08-21 18:06:27

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号